Adamas Pharmaceuticals Inc·4

Feb 18, 7:11 PM ET

Adamas Pharmaceuticals Inc 4

4 · Adamas Pharmaceuticals Inc · Filed Feb 18, 2015

Insider Transaction Report

Form 4
Period: 2015-02-17
Transactions
  • Sale

    Common Stock

    2015-02-17$16.54/sh1,000$16,54049,778 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Documents

2 files
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION

  • EX-24.4_562964

    POA DOCUMENT